Literature DB >> 16702373

Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.

Scott J Hebbring1, Henna Fredriksson, Kirsten A White, Christiane Maier, Charles Ewing, Shannon K McDonnell, Steven J Jacobsen, James Cerhan, Daniel J Schaid, Tarja Ikonen, Ville Autio, Teuvo L J Tammela, Kathleen Herkommer, Thomas Paiss, Walther Vogel, Marta Gielzak, Jurga Sauvageot, Johanna Schleutker, Kathleen A Cooney, William Isaacs, Stephen N Thibodeau.   

Abstract

The Nijmegen breakage syndrome 1 (NBS1) gene, which participates in DNA double strand break repair, has been postulated to be a susceptibility factor for a number of cancers, including prostate cancer. Numerous mutations have been identified in NBS1, including the founder mutation 657del5. In this study, a number of analyses were done to determine whether mutations in NBS1 are associated with an increased risk for prostate cancer. The frequency of the 657del5 mutation in both familial prostate cancer cases (1,819 affected men among 909 families) and sporadic prostate cancer cases (1,218 affected men) collected from five centers participating in the International Consortium for Prostate Cancer Genetics were compared with that found in 697 normal controls. Seven individuals were identified to carry the mutation among the 3,037 cases screened: four in the familial group (three from one family and one from another) and three in the sporadic cases. The carrier frequency was 0.22% (2 of 909) for the probands and 0.25% (3 of 1,218) for the sporadic cases of prostate cancer. The 657del5 mutation was not detected in either the 293 unaffected members of the prostate cancer families or in the 697 control samples tested. The entire NBS1 gene was also sequenced in 20 of the youngest affected individuals from the Finnish group of familial cases to identify the presence of possible mutations in this high-risk group. One rare (D95N) and one common (E185Q) missense alteration was identified. More detailed analyses of the E185Q polymorphism, along with a third rare variant (R215W), failed to show an association with prostate cancer. Because the 657del5 mutation was absent from the control population, we are unable to determine if this alteration predisposes to prostate cancer. However, our data does suggest that mutations within NBS1, and in particular, 657del5, do not significantly contribute to the overall prostate cancer burden within our patient samples.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16702373     DOI: 10.1158/1055-9965.EPI-05-0910

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  20 in total

Review 1.  Single nucleotide polymorphisms in DNA repair genes and prostate cancer risk.

Authors:  Jong Y Park; Yifan Huang; Thomas A Sellers
Journal:  Methods Mol Biol       Date:  2009

2.  Heterozygous p.I171V mutation of the NBN gene as a risk factor for lung cancer development.

Authors:  Ewelina Maria Kałużna; Jolanta Rembowska; Iwona Ziółkowska-Suchanek; Bogna Świątek-Kościelna; Piotr Gabryel; Wojciech Dyszkiewicz; Jerzy Stanisław Nowak
Journal:  Oncol Lett       Date:  2015-09-17       Impact factor: 2.967

Review 3.  Association between the NBS1 Glu185Gln polymorphism and lung cancer risk: a systemic review and meta-analysis.

Authors:  Lixin Wang; Jinsong Cheng; Jinyu Gao; Jipeng Wang; Xiaoning Liu; Liwen Xiong
Journal:  Mol Biol Rep       Date:  2012-12-29       Impact factor: 2.316

4.  Identification of a novel NBN truncating mutation in a family with hereditary prostate cancer.

Authors:  Kimberly A Zuhlke; Anna M Johnson; Linda A Okoth; Elena M Stoffel; Christiane M Robbins; Waibov A Tembe; Claudia A Salinas; S Lilly Zheng; Jianfeng Xu; John D Carpten; Ethan M Lange; William B Isaacs; Kathleen A Cooney
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

5.  Tobacco smoking, NBS1 polymorphisms, and survival in lung and upper aerodigestive tract cancers with semi-Bayes adjustment for hazard ratio variation.

Authors:  Tingting Yang; Po-Yin Chang; Sungshim Lani Park; Delara Bastani; Shen-Chih Chang; Hal Morgenstern; Donald P Tashkin; Jenny T Mao; Jeanette C Papp; Jian-Yu Rao; Wendy Cozen; Thomas M Mack; Sander Greenland; Zuo-Feng Zhang
Journal:  Cancer Causes Control       Date:  2013-10-29       Impact factor: 2.506

6.  NBS1 Glu185Gln polymorphism and susceptibility to urinary system cancer: a meta-analysis.

Authors:  Ying Zhang; Yu-Shan Huang; Wen-Qian Lin; Shao-Dan Zhang; Qi-Wen Li; Ye-Zhu Hu; Rong-Liang Zheng; Tao Tang; Xi-Zhao Li; Xiao-Hui Zheng
Journal:  Tumour Biol       Date:  2014-07-30

Review 7.  Mystery of DNA repair: the role of the MRN complex and ATM kinase in DNA damage repair.

Authors:  Kamila Czornak; Sanaullah Chughtai; Krystyna H Chrzanowska
Journal:  J Appl Genet       Date:  2008       Impact factor: 3.240

8.  NBS1 Glu185Gln polymorphism and cancer risk: update on current evidence.

Authors:  Ya-Zhou He; Xiao-Sa Chi; Yuan-Chuan Zhang; Xiang-Bing Deng; Jia-Rong Wang; Wen-Yu Lv; Yan-Hong Zhou; Zi-Qiang Wang
Journal:  Tumour Biol       Date:  2013-08-27

9.  NBS1 Heterozygosity and Cancer Risk.

Authors:  Alessandra di Masi; Antonio Antoccia
Journal:  Curr Genomics       Date:  2008-06       Impact factor: 2.236

10.  Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer.

Authors:  Sylvie Desjardins; Joly Charles Beauparlant; Yvan Labrie; Geneviève Ouellette; Francine Durocher
Journal:  BMC Cancer       Date:  2009-06-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.